Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for arthritis.

P D Robbins1, C H Evans, Y Chernajovsky

  • 1Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Gene Therapy
|May 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Home delivery for chondrocytes.

Osteoarthritis and cartilage·2025
Same author

How to Cure Rhus Poisoning.

The Homoeopathic physician·2023
Same author

Enthesis: not the same in each localisation - a molecular, histological and biomechanical study.

European cells & materials·2022
Same author

Mechanical and strain behaviour of human Achilles tendon during in vitro testing to failure.

European cells & materials·2022
Same author

Reverse dynamisation: a modern perspective on Stephan Perren's strain theory.

European cells & materials·2021
Same author

Healing of sub-critical femoral osteotomies in mice is unaffected by tacrolimus and deletion of recombination activating gene 1.

European cells & materials·2021
Same journal

Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

Gene therapy·2026
Same journal

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Gene therapy·2026
Same journal

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same journal

Applications of genome editing technologies in the treatment of human diseases.

Gene therapy·2026
Same journal

High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

Gene therapy·2026
Same journal

AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

Gene therapy·2026
See all related articles

Gene therapy offers a promising alternative for rheumatoid arthritis (RA) treatment, providing sustained delivery of anti-inflammatory agents. This review covers preclinical and clinical advancements in arthritis gene therapy, highlighting future directions.

Area of Science:

  • Immunology
  • Biotechnology
  • Medical Research

Background:

  • Rheumatoid arthritis (RA) is an autoimmune disease causing joint inflammation, cartilage/bone degradation, and potential systemic complications.
  • Current biological agents for RA are effective but require frequent administration.
  • Gene transfer presents a novel approach for sustained, targeted delivery of therapeutic agents for arthritis.

Purpose of the Study:

  • To review the current status of preclinical and clinical gene therapy for arthritis.
  • To summarize the advantages and disadvantages of various vectors, target cells, and therapeutic genes.
  • To outline future directions in arthritis gene therapy research.

Main Methods:

  • Review of preclinical studies in animal models (mouse, rat, rabbit, horse).

Related Experiment Videos

  • Analysis of Phase I clinical trial data.
  • Synthesis of information on different gene therapy components (vectors, cells, genes).
  • Main Results:

    • Gene transfer efficacy demonstrated in multiple animal models of arthritis.
    • Feasibility of arthritis gene therapy supported by Phase I clinical trial results.
    • Ongoing development of diverse vectors, target cells, and therapeutic genes.

    Conclusions:

    • Gene therapy is a viable and advancing treatment strategy for rheumatoid arthritis.
    • Further research and clinical trials are essential to optimize gene therapy approaches for arthritis.
    • The field of arthritis gene therapy holds significant potential for improved patient outcomes.